Literature DB >> 28360650

Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome.

Adem Balikci1, Murat Erdem1, Uğur Keskin2, Selma Bozkurt Zincir3, Murat Gülsün1, Fatih Özçelik4, Emin Özgür Akgül5, Süleyman Akarsu1, Muzaffer Öztosun6, Ali Ergün2.   

Abstract

INTRODUCTION: Polycystic Ovary Syndrome (PCOS) is a syndrome of heterogeneous nature, affecting multiple systems, particularly the endocrine system. We propose to investigate the possible relationships among hormonal changes, levels of anxiety, depression, and anger in patients with PCOS.
METHOD: Forty-four female patients with PCOS and 44 body mass index (BMI )-matched healthy women participated in this study. We measured the sociodemographic features, some serum hormonal levels (insulin, gonadotropins, prolactin, dehydroepiandrosterone sulfate (DHEAS), thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), 17 OH-progesterone, and total and free testosterone), and some other biochemical parameters of the participants. Also, all participants completed the Trait Anger-Anger Expression Scale (STAS), Beck Depression, and Beck Anxiety Inventories. We evaluated the psychiatric scale scores obtained from PCOS patients and control subjects. We used the independent-samples t-test for parametric data to evaluate normal distribution, and Mann-Whitney U-test was used for both abnormally distributed and nonparametric data. We used Pearson correlation analysis to evaluate the potential connection between the two groups' data.
RESULTS: The mean ages of the patients with PCOS and control subjects who participated in this study were 27.3±5.6 and 27.4±6.1 years, respectively. The measures of BMI, insulin, luteinizing hormone (LH), DHEAS, and total testosterone serum levels in the patient group were significantly higher than in the control group (p<.05). There was a statistically significant positive correlation between Beck anxiety scores and serum DHEAS levels (Pearson r=.4366, P=.0001). We found significant differences between the two groups in terms of trait anger, anger control, outward and inward anger, anxiety level, and depression scores (P<.05).
CONCLUSION: Anxiety symptoms indicate a stronger relationship compared to depression with DHEAS serum levels via the autonomic nervous system, considering the gamma-aminobutyric acid (GABA)-antagonistic effect of DHEAS. Obesity, hirsutism, and infertility may reduce self-confidence and create depressive symptoms in patients with PCOS. In addition, changes in hormonal levels may lead to anxiety directly. Possibly, depressive symptoms are a secondary reflection of these changes.

Entities:  

Keywords:  DHEAS; Polycystic ovary syndrome; anger; anxiety; depression; testosterone

Year:  2014        PMID: 28360650      PMCID: PMC5353166          DOI: 10.5152/npa.2014.6898

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  23 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice.

Authors:  L B Nicolas; W Pinoteau; S Papot; S Routier; G Guillaumet; S Mortaud
Journal:  Brain Res       Date:  2001-12-20       Impact factor: 3.252

3.  The psychological dimensions of infertility.

Authors:  Adrienne D Kraft; Joseph Palombo; Dorena Mitchell; Catherine Dean; Steven Meyers; Anne Wright Schmidt
Journal:  Am J Orthopsychiatry       Date:  1980-10

4.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

5.  Racial and economic demographics of couples seeking infertility treatment.

Authors:  J A Green; J C Robins; M Scheiber; S Awadalla; M A Thomas
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

6.  Young women's experiences living with polycystic ovary syndrome.

Authors:  Theresa R Weiss; Sandra Minor Bulmer
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2011-11-03

7.  Serum androgens and depression in women with facial hirsutism.

Authors:  L H Shulman; L DeRogatis; R Spielvogel; J L Miller; L I Rose
Journal:  J Am Acad Dermatol       Date:  1992-08       Impact factor: 11.527

8.  DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range.

Authors:  E Friess; L Trachsel; J Guldner; T Schier; A Steiger; F Holsboer
Journal:  Am J Physiol       Date:  1995-01

9.  Psychosomatic assessment of hirsute women.

Authors:  G A Fava; S Grandi; G Savron; G Bartolucci; G Santarsiero; G Trombini; C Orlandi
Journal:  Psychother Psychosom       Date:  1989       Impact factor: 17.659

Review 10.  Hypothalamic involvement in sexuality and hostility: comparative psychological aspects.

Authors:  N E Van de Poll; S H Van Goozen
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

View more
  4 in total

1.  Auricular points acupressure for insulin resistance in overweight/obese women with polycystic ovary syndrome: protocol for a randomised controlled pilot trial.

Authors:  Yan Li; Lihui Hou; Yingji Wang; Liangzhen Xie; Meiwei Zhang; Zimeng Pan; Yangyang Li; Yicheng Ding; Miao Sun; Yufang Qu; Songjiang Liu
Journal:  BMJ Open       Date:  2019-05-28       Impact factor: 2.692

2.  Polycystic Ovary Syndrome in adolescents: a qualitative study.

Authors:  Marzieh Saei Ghare Naz; Fahimeh Ramezani Tehrani; Giti Ozgoli
Journal:  Psychol Res Behav Manag       Date:  2019-08-22

3.  Polycystic ovary syndrome and its impact on Iranian women's quality of life: a population-based study.

Authors:  Zahra Behboodi Moghadam; Bita Fereidooni; Mohsen Saffari; Ali Montazeri
Journal:  BMC Womens Health       Date:  2018-10-11       Impact factor: 2.809

4.  Decreased Serum Level of Gamma-amino Butyric Acid in Egyptian Infertile Females with Polycystic Ovary Syndrome is Correlated with Dyslipidemia, Total Testosterone and 25(OH) Vitamin D Levels.

Authors:  Rasha A Radwan; Nermeen Z Abuelezz; Sahar M Abdelraouf; Engy M Bakeer; Abdullah A Abd El Rahman
Journal:  J Med Biochem       Date:  2019-01-22       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.